GSK3β and the control of infectious bacterial diseases

Trends Microbiol. 2014 Apr;22(4):208-17. doi: 10.1016/j.tim.2014.01.009. Epub 2014 Mar 4.

Abstract

Glycogen synthase kinase 3β (GSK3β) has been shown to be a crucial mediator of the intensity and direction of the innate immune system response to bacterial stimuli. This review focuses on: (i) the central role of GSK3β in the regulation of pathogen-induced inflammatory responses through the regulation of pro- and anti-inflammatory cytokine production, (ii) the extensive ongoing efforts to exploit GSK3β for its therapeutic potential in the control of infectious diseases, and (iii) the increasing evidence that specific pathogens target GSK3β-related pathways for immune evasion. A better understanding of complex bacteria-GSK3β interactions is likely to lead to more effective anti-inflammatory interventions and novel targets to circumvent pathogen colonization and survival.

Keywords: GSK3β; TLRs; cytokines; immune evasion; inflammation; septic shock.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Bacteria / immunology*
  • Bacterial Infections / immunology*
  • Cytokines / metabolism
  • Glycogen Synthase Kinase 3 / metabolism*
  • Glycogen Synthase Kinase 3 / therapeutic use
  • Glycogen Synthase Kinase 3 beta
  • Host-Pathogen Interactions*
  • Humans
  • Immune Evasion
  • Immunity, Innate*
  • Immunologic Factors / metabolism
  • Immunologic Factors / therapeutic use
  • Models, Biological

Substances

  • Cytokines
  • Immunologic Factors
  • GSK3B protein, human
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3